| Item type |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2009-01-06 |
| タイトル |
|
|
タイトル |
Metformin Use in an Obese Diabetic Patient from Weeks 1 to 21 of Pregnancy. |
| 言語 |
|
|
言語 |
eng |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
metformin |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
continuous subcutaneous insulin injection |
| キーワード |
|
|
主題Scheme |
Other |
|
主題 |
macrosomia |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 著者 |
Nagai, Takashi
Negishi, Tetuo
Imamura, Makoto
Mori, Masatomo
|
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
A 43-year-old diabetic woman was admitted in the 15th week of her first pregnancy. When HbAlc levels were 8.2%, we began diet therapy and continuous subcutaneous insulin infusion (CSII) therapy. The HbAlc levels subsequently ranged from 6.2 to 6.7%. She was delivered without complications of a healthy male infant (3120g) in the 38th week. Metformin was then administered. Six months later she was diagnosed as being in the 21st week of pregnancy. We changed from metformin to CSII therapy immediately. The HbAlc levels had ranged from 6.0 to 6.4% before the CSII therapy and from 5.8 to 6.3% after the CSII therapy during the entire second pregnancy. A macrosomia delivery (4070g) occurred in the 37th week. Although glycemic control was better during the 2nd pregnancy than the 1st pregnancy, metformin use until the 21st week may have induced macrosomia. |
| 書誌情報 |
The Kitakanto medical journal = 北関東医学
巻 55,
号 1,
p. 37-39,
発行日 2005-02-01
|
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1343-2826 |
| 書誌レコードID |
|
|
収録物識別子タイプ |
NCID |
|
収録物識別子 |
AN10585677 |
| フォーマット |
|
|
内容記述タイプ |
Other |
|
内容記述 |
application/pdf |
| 著者版フラグ |
|
|
出版タイプ |
VoR |
|
出版タイプResource |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
| 出版者 |
|
|
出版者 |
北関東医学会 |
| 資源タイプ |
|
|
内容記述タイプ |
Other |
|
内容記述 |
Journal Article |
| 更新日 |
|
|
日付 |
2017-03-27 |
|
日付タイプ |
Created |
55_37.pdf (356.7 kB)
